Informing decisions concerning adjuvant chemotherapy following surgical resection for non-small cell lung cancer: A mathematical modelling study

Lung Cancer

Volumn 53, Issue 2, 2006, Pages 153-156

  Utley, Martin ^a   Paschalides, Christos ^a   Treasure, Tom ^b  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b GUY S HOSPITAL   (United Kingdom)

Author keywords

Adjuvant chemotherapy; Lung cancer; Mathematical modelling; NSCLC; Surgery

Indexed keywords

ARTICLE; CANCER ADJUVANT THERAPY; CANCER SURGERY; DECISION MAKING; LUNG NON SMALL CELL CANCER; MATHEMATICAL MODEL; PRIORITY JOURNAL;

ANTINEOPLASTIC AGENTS; CARCINOMA, NON-SMALL-CELL LUNG; CHEMOTHERAPY, ADJUVANT; DECISION MAKING; HUMANS; LUNG NEOPLASMS; MODELS, THEORETICAL; NEOPLASM STAGING; PNEUMONECTOMY; RESEARCH DESIGN; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 33745598775     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lungcan.2006.04.009     Document Type: Article

References (15)

1. Sedrakyan A., van Der Meulen J., O'Byrne K., Prendiville J., Hill J., and Treasure T. Postoperative chemotherapy for non-small cell lung cancer: a systematic review and meta-analysis. J Thorac Cardiovasc Surg 128 (2004) 414-419
2. National Collaborating Centre for Acute Care. Diagnosis and treatment of lung cancer (2005), National Collaborating Centre for Acute Care, London. http://www.rcseng.ac.uk/ available from www.rcseng.ac.uk
3. Fergusson D., Glass K., Hutton B., and Shapiro S. Randomised controlled trials of aprotinin in cardiac surgery: could clinical equipoise have stopped the bleeding?. Clin Trials 2 (2005) 218-232
4. Chalmers I. The scandalous failure of science to cumulate evidence scientifically. Clin Trials 2 (2005) 229-231
5. Young C., and Horton R. Putting clinical trials into context. Lancet 366 (2005) 107-108
6. Burdett S., Steward L., and Pignon J.P. Chemotherapy in non-small cell lung cancer: an update of an individual patient data-based meta-analysis. J Thorac Cardiovas Surg 129 (2005) 1205-1206
7. Jackson R.R.P., and Aspden P. Treatment evaluation-a modelling approach with application to acute myeloid leukaemia. J OR Soc 30 (1979) 11-22
8. Jackson R.R.P., Birkhead B.G., Belt R., Lister T.A., and Gregory W.M. Application of Jackson, Aspen Acute Myeloid Leukaemia Model. J OR Soc 33 (1982) 211-216
9. Pearce R.M., Gallivan S., and Jackson R.R.P. Patient progress modelling for small cell lung cancer. Eur J Cancer 29 (1993) 734-737
10. Mountain C.F., Libshitz H.I., and Hermes H.E. Lung cancer handbook for staging and imaging (1997), Mountain and Libshitz, Houston
11. Mountain C.F. A new international staging system for lung cancer. Chest 89 4 Suppl (1986) 225S-233S
12. Collett D. Modelling survival data in medical research (1994), Chapman and Hall, London
13. Naruke T., Tsuchiya R., Kondo H., Asamura H., and Nakayama H. Prognosis and survival after resection for Bronchogenic carcinoma based on the 1997 TNM-staging classification: the Japanese Experience. Ann Thorac Surg 71 (2001) 1759-1764
14. Birim O., Kappetein A.P., van Klaveren R.J., and Bogers A.J. Prognostic factors in non-small cell lung cancer surgery. Eur J Surg Oncol 32 1 (2006) 12-23
15. Visbal A., Leighl N., Feld R., and Shepherd F. Adjuvant chemotherapy for early stage non-small cell lung cancer. Chest 128 (2005) 2933-2943